Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-18.72	183.73	226.06
Graham Fair Price	-8.59	1.40	1.53
PEG	-135.89	-5.69	-2.41
Price/Book	-22.90	3.47	4.50
Price/Cash Flow	-11.58	226.11	-255.71
Prices/Earnings	-12.11	81.30	92.51
Price/Sales	-23.06	11.74	15.25
Price/FCF	-11.58	226.11	-255.71
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-7.46	0.19	0.21
Operating Margin	-61.49	0.03	0.07
ROA	-11.39	< 0.005	< 0.005
ROE	0.01	0.01	-12.27
ROIC	0.01	< 0.005	-61.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.61	0.11	439.84
Dividends QOQ	0.83	28.27	3303.46
EBIT QOQ	-0.06	-0.62	-974.13
EPS QOQ	-0.38	-0.14	62.74
FCF QOQ	0.18	1.85	915.70
Revenue QOQ	-0.12	-0.02	81.80
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	83.89	88.34	5.31
Days Sales Outstanding (DSO)	306.60	296.73	-3.22
Inventory Turnover	1.07	1.02	-5.04
Debt/Capitalization	0.22	0.31	44.29
Quick Ratio	1.38	1.43	3.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.93	3.22	9.68
Cash	1.29	1.00	-22.57
Capex	-0.07	0.08	26.04
Free Cash Flow	-0.05	0.04	-14.90
Revenue	0.87	0.85	-2.20
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.68	1.66	-1.41
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.06	7.88	94.27
Naive Interpretation	Member

06 - Financial Health · Weak

Rating